RIS

1-HYDROXY-2-(3-PYRIDINYL)ETHYLIDENE BIS-PHOSPHONIC ACID

Find entries where: RIS

is present as a standalone ligand in 19 entries

Find related ligands:

Chemical Component Summary
Name	1-HYDROXY-2-(3-PYRIDINYL)ETHYLIDENE BIS-PHOSPHONIC ACID
Synonyms	Risedronate
Identifiers	(1-hydroxy-1-phosphono-2-pyridin-3-yl-ethyl)phosphonic acid
Formula	C₇ H₁₁ N O₇ P₂
Molecular Weight	283.112
Type	NON-POLYMER
Isomeric SMILES	c1cc(cnc1)CC(O)(P(=O)(O)O)P(=O)(O)O
InChI	InChI=1S/C7H11NO7P2/c9-7(16(10,11)12,17(13,14)15)4-6-2-1-3-8-5-6/h1-3,5,9H,4H2,(H2,10,11,12)(H2,13,14,15)
InChIKey	IIDJRNMFWXDHID-UHFFFAOYSA-N

Chemical Details
Formal Charge	0
Atom Count	28
Chiral Atom Count	0
Bond Count	28
Aromatic Bond Count	6

Drug Info: DrugBank

DrugBank ID	DB00884
Name	Risedronic acid
Groups	approved investigational
Description	Risedronic acid is a third generation bisphosphonate that is used for the treatment of some forms of osteoperosis and Paget's disease[FDA Label][A959,A203111]. It functions by preventing resorption of bone[FDA Label][A959].
Synonyms	Risedronic acid Acide risédroniqe Acido risedronico Risedronsäure Risedronate sodium hemi-pentahydrate Risedronate sodium Risedronate sodium monohydrate Acidum risedronicum Risedronate
Brand Names	Sandoz Risedronate Ratio-risedronate Actonel with Calcium Apo-risedronate Jamp-risedronate Atelvia Actonel Actonel With Calcium Risedronate Sodium Amorphous Fv2910cl Aa-risedronate Dr Mylan-risedronate PMS-risedronate Actonel Dr Teva-risedronate Risedronate Sodium PMS-risedronate Plus Calcium Pendo-risedronate Teva-risedronate/calcium Actonel Plus Calcium Auro-risedronate PHL-risedronate Q-risedronate Riva-risedronate Actonel Sachet Kit Ntp-risedronate Dom-risedronate Risedronate
Indication	Risedronic acid is indicated for the treatment of osteoperosis in men, treatment of Paget's disease, treatment and prevention of osteoperosis in postmenopausal women, and treatment and prevention of glucocorticoid-induced osteoperosis[FDA Label].
Categories	Agents Causing Muscle Toxicity Bisphosphonates Bone Density Conservation Agents Calcium-Regulating Hormones and Agents Cardiovascular Agents Drugs Affecting Bone Structure and Mineralization Drugs for Treatment of Bone Diseases Membrane Transport Modulators Musculo-Skeletal System Organophosphonates Organophosphorus Compounds Pyridines
ATC-Code	M05BB07 M05BB02 M05BB04 M05BA07
CAS number	105462-24-6

Drug Targets

Name	Target Sequence	Pharmacological Action	Actions
Hydroxylapatite	-	unknown	antagonist
Farnesyl pyrophosphate synthase	MPLSRWLRSVGVFLLPAPYWAPRERWLGSLRRPSLVHGYPVLAWHSARCW...	unknown	inhibitor
Prostaglandin G/H synthase 2	MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFY...	unknown	inducer

Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682